CHRISTOPHER COLOPINTO: Open Payments
NPI 1659341923 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,848 in 123 payments from 25 companies in 2025. Trend: 2023 $1,850 · 2024 $2,333 · 2025 $2,848
Food & beverage: $2,848
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $548 |
| Novo Nordisk Inc | 11 | $323 |
| Kowa Pharmaceuticals America, Inc. | 17 | $315 |
| Otsuka America Pharmaceutical, Inc. | 8 | $241 |
| Merck Sharp & Dohme LLC | 12 | $221 |
| Amgen Inc. | 19 | $187 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $146 |
| Madrigal Pharmaceuticals | 1 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
Products named: ZORYVE, REXULTI, AIRSUPRA, Ozempic, BREZTRI, Kerendia, CAPVAXIVE, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
